Announces addition of Exhibition and Workshop
|
||||||||||
BOSTON, April 05, 2018 -- Building on its successful inaugural earlier this year, Additive Manufacturing Strategies Summit on Medical and Dental 3D Printing will return, January 2931, 2019, at The Hynes Center in Boston. This year additions include:
- The original pioneering 3D-printed medical and dental business conference, but with separate medical and dental tracks
- An exhibition floor displaying the latest products and technologies related to additive medicine and dentistry
- An educational workshop providing a complete overview of medical/dental 3DP. This workshop will be held on January 29, with the conference scheduled for January 30-31.
This event is being produced by SmarTech Publishing and 3DPrint.com. Its first iteration was held in Washington DC in early 2018 and saw a gathering of nearly 100 of the brightest minds and leading authorities on medical and dental 3D printing and additive manufacturing, along with presentations of SmarTech’s latest market forecasts in this exciting area.
The 2018 event attendees had direct access to more than 30 speakers and panelists. Companies and organizations represented included Carbon, GE Additive, HP, 3D Systems, EOS, the Mayo Clinic, the FDA, and many others.
See here for last year's complete schedule.
Sign-up for our newsletter to receive updates and get access to the best early bird pricing; registration will be open soon. For exhibitor and sponsorship opportunities please email [email protected] or call 917-403-6300.


AST SpaceMobile Joins MSCI ACWI Index as Largest New Addition, Boosting Market Visibility
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible
Salesforce Workforce Reduction Affects Fewer Than 1,000 Roles Amid Ongoing Restructuring
Air New Zealand Cabin Crew Strike Set for February 12–13 Amid Failed Talks
Petrobras Posts Record Oil Exports as Production Surge Fuels Global Expansion
Cloudflare Forecasts Strong Revenue Growth as AI Fuels Cloud Services Demand
FDA Rejects Review of Moderna’s Flu Vaccine Application, Shares Slide
Moderna Stock Drops After FDA Declines Review of mRNA Flu Vaccine
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
Treasury Wine Estates Shares Surge After U.S. Dispute Settlement and Earnings Upgrade
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Russia Signals Further Restrictions on Telegram Amid Ongoing Regulatory Disputes
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision
Trump Administration Plans Chip Tariff Exemptions for Big Tech Amid AI Data Center Push
Ralph Lauren Unveils Elegant Fall 2026 Women’s Collection Ahead of New York Fashion Week
xAI Co-Founder Jimmy Ba Departs as Elon Musk’s AI Startup Faces Turbulence
Amazon Explores AI Content Marketplace With Media Publishers 



